When people develop myelodysplastic neoplasms (MDS), the healthy maturation of blood cells is impaired. Severe forms, known as higher-risk MDS, are characterized by rapid progression, severe symptoms and often a transition ...
Jan 22, 2024
0
17
Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function. The disease affects more than 12 million people worldwide, ...
Jan 22, 2024
1
46
A multicenter study led by Amsterdam UMC and conducted in nine Dutch Intensive Care Units (ICUs) has shown that tailoring a computerized decision support system (CDSS) to the ICU environment significantly reduced the number ...
Jan 20, 2024
0
36
Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers ...
Jan 18, 2024
0
7
Supply bottlenecks for medications present major challenges to health care systems the world over. In Switzerland, for instance, just under 1,000 drugs that are covered by statutory health insurance are currently unobtainable.
Jan 18, 2024
0
8
Bacterial infections can lead to the formation of abscesses—pockets of dead cells and debris surrounded by inflammatory immune cells. Bacteria multiply within abscesses, causing more inflammation and further damage to surrounding ...
Jan 17, 2024
0
48
Physicians who are notified that a patient has died of a drug overdose are more judicious in issuing controlled substances if the notification includes a plan for what to do during subsequent patient visits, according to ...
Jan 12, 2024
0
7
Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can cut out the time and expense ...
Jan 12, 2024
0
12
People diagnosed with a life-threatening cardiac condition have been given new hope, thanks to a ground-breaking new drug that protects the heart developed by researchers from UCL and the Royal Free Hospital.
Jan 11, 2024
0
63
A new study led by Menzies School of Health Research has provided further insight into the cost-effectiveness of a new malaria medication, tafenoquine, to treat vivax malaria.
Jan 11, 2024
0
51
